 Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of 1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific markets ENGLEWOOD, CO ACCESSWIRE May 13, 2021 Viveve Medical, Inc. NASDAQ:VIVE, a medical technology company focused on womens intimate health, today reported financial results for the quarter ended March 31, 2021, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today. During the first quarter of 2021, Viveve continued its focus on advancing its stress urinary incontinence SUI clinical development program. 